Bayview Pharmacy's Glipizide 2.5 mg/0.1 ml Topical Lipoderm® (Vet) is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, providing targeted treatment for conditions such as diabetes mellitus, hyperlipidemia, hyperglycemia, hypoglycemia, and obesity in veterinary patients. The gel-like consistency ensures optimal absorption of the active ingredients.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present the compounded formulation of Glipizide 2.5 mg/0.1 ml Topical Lipoderm® (Vet). This semisolid formulation is dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment or absorption of active ingredients in a gel-like consistency. It is designed to provide relief from a variety of conditions.
Glipizide, an anti-diabetic medication, works to reduce blood sugar levels, making this formulation ideal for managing conditions such as diabetes, hyperglycemia, and hypoglycemia. Lipoderm®, a topical delivery system, enhances the absorption of the medication, ensuring optimal efficacy. Beyond its use for blood sugar regulation, this formulation can also be applied to treat skin conditions such as psoriasis, eczema, and dermatitis, providing a versatile solution for diverse healthcare needs.
The Glipizide 2.5 mg/0.1 ml Topical Lipoderm® (Vet) formulation is user-friendly and provides rapid relief from the symptoms of various disease states. It is crucial to adhere to the instructions provided by your healthcare provider when using this formulation to ensure the best possible results. If you have any questions or concerns about using this formulation, please do not hesitate to contact us at Bayview Pharmacy.
This compounded formulation of Glipizide 2.5 mg/0.1 ml Topical Lipoderm® (Vet) is a semisolid preparation designed for easy and precise application on the skin. It is dispensed through a pump mechanism, which allows for targeted treatment or absorption of the active ingredients. The gel-like consistency of the formulation ensures that it adheres well to the skin, providing a sustained release of the medication.
It is specifically indicated for the treatment of various disease states in animals and is not intended for human use. The formulation may interact with other medications, supplements, or herbal products that the animal may be taking. Therefore, it is crucial for pet owners to inform their veterinarian about any other medications, supplements, or herbal products their pet is currently on.
Furthermore, this formulation may also interact with certain foods. Any changes in the animal's diet should be communicated to the veterinarian to avoid any potential adverse reactions. Pet owners should also be aware of any potential side effects associated with this formulation. If any side effects occur, it is advised to contact the veterinarian immediately.
If you have any questions or concerns about this formulation or its interactions, please consult with your veterinarian for further information.
Glipizide 2.5 mg/0.1 ml Topical Lipoderm® (Vet) is a specially compounded formulation designed to manage diabetes in pets, specifically cats and dogs. This unique medication combines the power of glipizide, a sulfonylurea that stimulates the pancreas to produce more insulin, thereby helping to regulate blood sugar levels, with Lipoderm®, a liposomal delivery system that enhances the absorption of glipizide through the skin.
This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The gel-like consistency ensures targeted treatment or absorption of the active ingredients. It is designed to be applied directly to the skin of the animal, ideally on a clean, dry area that is free from any breaks or irritation.
Glipizide 2.5 mg/0.1 ml Topical Lipoderm® (Vet) is typically administered once daily, or as directed by a veterinarian. It is crucial to follow the veterinarian's instructions when applying this medication to ensure its effectiveness and to avoid any potential side effects.
Regular monitoring of the pet's blood sugar levels is essential while using this medication. If the pet's blood sugar levels become too low, it may be necessary for the veterinarian to adjust the dosage or frequency of the medication. Always consult with a veterinarian if you notice any changes in your pet's condition or behavior while using this medication.
If you have any questions about Glipizide 2.5 mg/0.1 ml Topical Lipoderm® (Vet) or need further guidance on its application, please do not hesitate to reach out. We are here to provide the support you need to ensure the health and well-being of your pet.
Glipizide 2.5 mg/0.1 ml Topical Lipoderm® (Vet) is a versatile compounded formulation that can be used to manage a variety of conditions. This formulation can also be utilized as a preventative measure for individuals with prediabetes, reducing the risk of progression to type 2 diabetes.
Furthermore, Glipizide 2.5 mg/0.1 ml Topical Lipoderm® (Vet) can be used to decrease the risk of cardiovascular disease in individuals diagnosed with type 2 diabetes. It is also beneficial in mitigating the risk of complications associated with diabetes, such as retinopathy, nephropathy, and neuropathy.
Another significant advantage of this formulation is its potential to reduce the risk of hypoglycemia in individuals with type 2 diabetes. It can also be used as a preventative measure against the development of metabolic syndrome in individuals with prediabetes.
If you have any questions or require further information about the use of Glipizide 2.5 mg/0.1 ml Topical Lipoderm® (Vet) for any of these conditions, please do not hesitate to contact us. We are here to provide you with the necessary guidance and support.
Glipizide 2.5 mg/0.1 ml Topical Lipoderm® (Vet) is a semisolid formulation that is dispensed through a pump mechanism. It is designed for easy and precise application on the skin for targeted treatment or absorption of active ingredients.
The active ingredient, Glipizide, is absorbed through the skin and into the bloodstream. This medication helps to control blood sugar levels in animals with diabetes.
Apply the medication directly to the skin as directed by your veterinarian. The pump mechanism allows for easy and precise application.
Glipizide 2.5 mg/0.1 ml Topical Lipoderm® (Vet) has a gel-like consistency.
This medication is specifically designed for veterinary use. However, it should only be used as directed by a veterinarian and may not be suitable for all animals.
If your pet has a reaction to this medication, contact your veterinarian immediately. Reactions can include redness, irritation, or other changes in the skin where the medication was applied.
Consult with your veterinarian before using this medication on a pregnant or nursing pet. The effects of this medication on unborn or nursing animals are not known.
If you miss a dose, apply it as soon as you remember. If it is close to the time for the next dose, skip the missed dose and go back to your regular dosing schedule. Do not double the dose.
Store this medication at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children and pets.
No, do not use this medication past its expiration date. The effectiveness of the medication may be reduced after this date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)